Before we begin, I'd like to remind you that this call contains forward-looking statements, which are our beliefs about ...

New Research Compilation Examines Clinical Studies on Tongkat Ali, Horny Goat Weed, Saw Palmetto, and Other Evidence-Based ...

Wasatch reports WGROX’s worst quarter in 20+ years, but reaffirms conviction in high-quality growth. See how the fund is ...

The Russell 2500 Index was up 9.00%. The Wasatch Long/Short Alpha Fund—Investor Class did not keep pace and finished the ...

Art and science building intelligence at the point of conversation enhances clinical decision-making and patient care across health systems.

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

We knew it was coming, and now it’s close. By the end of 2024, the US Food and Drug Administration (FDA) is expected to formally make reviews by a single institutional review board (sIRB) the standard ...

Introduction From 2012 to 2017, the Cervical Cancer Prevention in El Salvador (CAPE) piloted and scaled up a human ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.

Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion ...

Angie Mohr, CPA, CA, and CMA, has 18+ years of experience as a freelance finance writer. She is the author of Money$marts and Piggy Banks to Paycheck. David Kindness ...

Raises Full-year 2025 Total Revenues Guidance at the Midpoint; Reaffirms VOXZOGO Full-year Outlook 2025 Year-to-date Total Revenues Increased 11% Y/Y Led by More Than ...